Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:13 PM UTC
| NCT Number | NCT07283770 |
| Recruiting Status | Recruiting |
| Condition | Cystic Fibrosis |
| Phase | PHASE1 |
| Target Enrollment | 136 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | July 16, 2026 (Jul 16, 2026) |
As of August 31, 2026: Clinical trial NCT07283770 is currently recruiting participants. This phase1 study for cystic fibrosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07283770 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07283770 was last updated Jul 16, 2026 (July 16, 2026). HelloStudys verifies this status automatically.